论文信息 - Incidence and clinical progression of placebo-treated amyloid-negative subjects with mild-to-moderate Alzheimer's disease (AD): Results from the phase III PET substudies of bapineuzumab and solanezumab - 字舞流文

Incidence and clinical progression of placebo-treated amyloid-negative subjects with mild-to-moderate Alzheimer's disease (AD): Results from the phase III PET substudies of bapineuzumab and solanezumab

M. Mintun | E. Liu | E. Siemers | S. Salloway | A. Joshi | M. Pontecorvo | D. Skovronsky | B. Wyman | P. Yu | Jia Sun | R. Margolin | R. Brashear | K. Booth | R. Sperling | K. Sundell | K. Gregg | M. Lu | M. Schmidt